InsidersTradesSigma
Discover the full record of transactions filed by Moat Ross, Director General. Insider active across 1 company, notably Kiniksa Pharmaceuticals, Ltd.. In total, 2 disclosures have been logged. Activity tracked since 15 July 2021. The latest transaction was disclosed on 15 July 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 de 2 declaraciones
Ross Moat is the Chief Commercial Officer at Kiniksa Pharmaceuticals, Ltd. He is responsible for commercial strategy and sales development. Moat leverages his expertise to lead initiatives that support the company's growth.